257 related articles for article (PubMed ID: 25987536)
1. Salvage endoscopic nasopharyngectomy is superior to intensity-modulated radiation therapy for local recurrence of selected T1-T3 nasopharyngeal carcinoma – A case-matched comparison.
You R; Zou X; Hua YJ; Han F; Li L; Zhao C; Hong MH; Chen MY
Radiother Oncol; 2015 Jun; 115(3):399-406. PubMed ID: 25987536
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic surgery compared with intensity-modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial.
Liu YP; Wen YH; Tang J; Wei Y; You R; Zhu XL; Li J; Chen L; Ling L; Zhang N; Zou X; Hua YJ; Chen YM; Chen L; Lu LX; Chen MY; Wen WP
Lancet Oncol; 2021 Mar; 22(3):381-390. PubMed ID: 33600761
[TBL] [Abstract][Full Text] [Related]
3. Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma.
Liu YP; Lv X; Zou X; Hua YJ; You R; Yang Q; Xia L; Guo SY; Hu W; Zhang MX; Chen SY; Lin M; Xie YL; Liu LZ; Sun R; Huang PY; Fan W; Guo X; Hong MH; Chen MY
Cancer Commun (Lond); 2019 Nov; 39(1):75. PubMed ID: 31730020
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic surgery versus intensity-modulated radiotherapy in locally advanced recurrent nasopharyngeal carcinoma: a multicenter, case-matched comparison.
Liu Y; Huang N; Gao J; He B; Huang H; Wan L; Cai Q; Zhu Z; Zhou S; Wang J; Wang X; Qiu Q; Han F
J Otolaryngol Head Neck Surg; 2023 Nov; 52(1):72. PubMed ID: 37932841
[TBL] [Abstract][Full Text] [Related]
5. The Management of rNPC: Salvage Surgery vs. Re-irradiation.
Hao CY; Hao SP
Curr Oncol Rep; 2020 Jul; 22(9):86. PubMed ID: 32642860
[TBL] [Abstract][Full Text] [Related]
6. Salvage endoscopic nasopharyngectomy and intensity-modulated radiotherapy versus conventional radiotherapy in treating locally recurrent nasopharyngeal carcinoma.
Zou X; Han F; Ma WJ; Deng MQ; Jiang R; Guo L; Liu Q; Mai HQ; Hong MH; Chen MY
Head Neck; 2015 Aug; 37(8):1108-15. PubMed ID: 24764204
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Endoscopic Nasopharyngectomy Combined With Low-Dose Radiotherapy for Primary T1-2 Nasopharyngeal Carcinoma.
Zhang B; Li Y; Weng J; Huang B; Ban M; Lan G; Lu Y; Luo J; Qu S; Si Y
Technol Cancer Res Treat; 2021; 20():15330338211011975. PubMed ID: 33896244
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of clinical efficacy and the quality of life after endoscopic nasopharyngectomy for residual or recurrent nasopharyngeal carcinoma].
Chen Z; Qiu Q
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Nov; 50(11):896-903. PubMed ID: 26887993
[TBL] [Abstract][Full Text] [Related]
9. The role of nasopharyngectomy in the management of nasopharyngeal carcinoma.
Wang WH; Yeh CF; Lan MY
Curr Opin Otolaryngol Head Neck Surg; 2022 Feb; 30(1):3-12. PubMed ID: 34958319
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic Nasopharyngectomy Combined With Internal Carotid Artery Pretreatment for Recurrent Nasopharyngeal Carcinoma.
Wang ZQ; Xie YL; Liu YP; Zou X; Chen JH; Hua YJ; Gu YK; Ouyang YF; Yu ZK; Sun R; Huang PY; Chen MY
Otolaryngol Head Neck Surg; 2022 Mar; 166(3):490-497. PubMed ID: 34182810
[TBL] [Abstract][Full Text] [Related]
11. Preliminary evidence for endoscopic surgery combined with postoperative anti-PD-1 immunotherapy in advanced recurrent nasopharyngeal carcinoma.
Xu H; Li W; Zhang H; Wang H; Hu L; Gu Y; Wang D
BMC Cancer; 2023 Dec; 23(1):1259. PubMed ID: 38129782
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic surgery is superior to intensity-modulated radiotherapy in the treatment of advanced recurrent nasopharyngeal carcinoma.
Li W; Zhang Q; Chen F; Xu H; Liu Q; Wang H; Zhang H; Liu Q; Gu Y; Li H; Sun X; Yu H; Wang D
Int Forum Allergy Rhinol; 2023 Feb; 13(2):140-150. PubMed ID: 35751380
[TBL] [Abstract][Full Text] [Related]
13. 5-year outcomes of salvage endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma.
Thamboo A; Patel VS; Hwang PH
J Otolaryngol Head Neck Surg; 2021 Feb; 50(1):12. PubMed ID: 33597031
[TBL] [Abstract][Full Text] [Related]
14. Effect of adaptive replanning in patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: a propensity score matched analysis.
Luo Y; Qin Y; Lang J
Clin Transl Oncol; 2017 Apr; 19(4):470-476. PubMed ID: 27718153
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of recurrent nasopharyngeal carcinoma patients treated with endoscopic nasopharyngectomy: a meta-analysis.
Yang J; Song X; Sun X; Liu Q; Hu L; Yu H; Wang D
Int Forum Allergy Rhinol; 2020 Aug; 10(8):1001-1011. PubMed ID: 32452124
[TBL] [Abstract][Full Text] [Related]
16. [Cost-effectiveness of endoscopic nasopharyngectomy in locally recurrent rT1-rT3 nasopharyngeal carcinoma: a study based on Markov model].
Chen MY; Wen WP; Li J; Liu YP; Chen MY; Tang J; Wen YH
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Nov; 57(11):1304-1310. PubMed ID: 36404655
[No Abstract] [Full Text] [Related]
17. Salvage Intensity-Modulated Radiation Therapy (IMRT) for Locally Recurrent Nasopharyngeal Cancer after Definitive IMRT: A Novel Scenario of the Modern Era.
Kong L; Wang L; Shen C; Hu C; Wang L; Lu JJ
Sci Rep; 2016 Sep; 6():32883. PubMed ID: 27616024
[TBL] [Abstract][Full Text] [Related]
18. Innovative application of internal carotid artery embolization in salvage endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma: A case-matched comparison.
Li W; Liu Q; Wang H; Zhang H; Liu Q; Hu L; Li H; Dai J; Sun X; Yu H; Wang D
Int Forum Allergy Rhinol; 2022 Jun; 12(6):838-848. PubMed ID: 34773719
[TBL] [Abstract][Full Text] [Related]
19. Five-year Survival Data on the Role of Endoscopic Endonasal Nasopharyngectomy in Advanced Recurrent rT3 and rT4 Nasopharyngeal Carcinoma.
Wong EHC; Liew YT; Loong SP; Prepageran N
Ann Otol Rhinol Laryngol; 2020 Mar; 129(3):287-293. PubMed ID: 31701754
[TBL] [Abstract][Full Text] [Related]
20. Impact of Radiotherapy Combined With Chemotherapy on Long-Term Outcomes of Patients With Recurrent Nasopharyngeal Carcinoma.
Li Y; Liu W; Xu Y; Guo LY; Weng YL; Huang ZW; Chen XC; Lin T; Lu J; Qiu SF
Technol Cancer Res Treat; 2023; 22():15330338231155721. PubMed ID: 36762400
[No Abstract] [Full Text] [Related]
[Next] [New Search]
